Background Hemodynamically-guided management using an implanted pulmonary artery
pressure sensor is indicated to reduce heart failure (HF) hospitalizations in patients with …

Background Previous studies have suggested that haemodynamic-guided management
using an implantable pulmonary artery pressure monitor reduces heart failure …

Background Hemodynamic-guided heart failure (HF) management using pulmonary artery
(PA) pressures reduces HF hospitalizations (HFHs) in previously hospitalized HF patients …

Background Trials evaluating implantable hemodynamic monitors to manage patients with
heart failure (HF) have shown reductions in HF hospitalizations but not mortality. Prior meta …

Background—No treatment strategies have been demonstrated to be beneficial for the
population for patients with heart failure (HF) and preserved ejection fraction (EF). Methods …

Background: Despite increased use of guideline-directed medical therapy (GDMT), some
patients with heart failure and reduced ejection fraction (HFrEF) remain at high risk for …

Abstract Background: In the CHAMPION (CardioMEMS Heart Sensor Allows Monitoring of
Pressure to Improve Outcomes in New York Heart Association NYHA Functional Class III …

Background: Ambulatory hemodynamic monitoring with an implantable pulmonary artery
(PA) sensor is approved for patients with New York Heart Association Class III heart failure …

Background In the CHAMPION trial, significant reductions in admissions to hospital for heart
failure were seen after 6 months of pulmonary artery pressure guided management …

Importance In a randomized clinical trial, heart failure (HF) hospitalizations were lower in
patients managed with guidance from an implantable pulmonary artery pressure sensor …